Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
Karla Hemming(University of Birmingham), Monica Taljaard(University of Ottawa), Joanne E. McKenzie(Monash University), Richard Hooper(Queen Mary University of London), Andrew Copas(MRC Clinical Trials Unit at UCL), JA Thompson(London School of Hygiene & Tropical Medicine), Mary Dixon‐Woods(University of Cambridge), Adrian Aldcroft(BMJ Group (United Kingdom)), A. Doussau(McGill University), Michael J. Grayling(MRC Biostatistics Unit), Caroline Kristunas(University of Leicester), Cory E. Goldstein(Western University), Marion Campbell(University of Aberdeen), Alan Girling(University of Birmingham), Sandra Eldridge(Queen Mary University of London), Mike J Campbell(University of Aberdeen), Richard Lilford(University of Warwick), Charles Weijer(Western University), Andrew Forbes(Monash University), Jeremy Grimshaw(University of Ottawa)
Cited by 487Open Access
Abstract
The stepped-wedge cluster randomised trial (SW-CRT) is a novel cluster randomised trial variant that is increasingly being used. It is particularly relevant for evaluating service innovations in learning healthcare organisations There has been an exponential increase in the use of this design over the past few years with an expected increase in publications in the near future.
Related Papers
No related papers found
Powered by citation graph analysis